Integration of CPDM's Model Creation in Clinical Trials

Cancer models generated from patients before, during, or post-clinical trial are valuable resources to study patients' trial responsiveness and could potentially serve as avatars to predict future treatment responsiveness.

Our team of clinical research coordinators offers processes for regulatory compliance to generate cancer models from clinical trial patients.

Please email models@dfci.harvard.edu to learn more about this service.